Moer-Able Tablet 1 mg (Finasteride)

Adult dose

Finasteride is generally administered orally at a dose of 1 mg once daily and can be taken regardless of meals. There is no evidence that increasing the dose enhances efficacy. Typically, treatment must be continued for at least 3 months to see therapeutic effects, and continuous administration is recommended to maintain treatment benefits. The duration of treatment and efficacy should be continuously evaluated. If the medication is discontinued, therapeutic effects will disappear within 12 months.

This medication should not be used by children or women. In particular, women who are pregnant or may become pregnant should not handle broken pieces of this medicine, as it could pose a risk to male fetuses if absorbed through the skin. During treatment, symptoms of depression or mood changes may occur, and if these symptoms appear, medical advice should be sought immediately. Pregnant women must not take this medication, as it poses a risk of genital abnormalities in male fetuses if taken by pregnant individuals. Additionally, individuals allergic to this medication or its components, those with specific lactose intolerance, and individuals allergic to soybean oil, soy, or peanuts should not take it. Patients with impaired liver function or issues with lipid metabolism should use this medication with caution, and patients with excessive lipid overload are advised to regularly monitor their blood lipid levels. While taking this medication, sexual function-related side effects may occur, including decreased libido, erectile dysfunction, and ejaculation disorders. If these symptoms occur, consultation with a physician is necessary, as symptoms generally improve after discontinuation of the drug. Also, unusual symptoms such as breast tenderness or enlargement and testicular pain may occur, so medical staff should be informed immediately if such symptoms are experienced. This medication has not shown significant interactions with other drugs, but if other medications are being taken, informing a physician or pharmacist is recommended. This medication should not be administered to pregnant women or nursing mothers, and its safety for children has not been established. It can be used in elderly patients without special dose adjustment, however, sufficient research on its effectiveness in this population has not been conducted. During treatment, the prostate-specific antigen (PSA) levels may decrease, so caution is needed when interpreting test results. There is no specific antidote for overdose, but it is important to adhere to the recommended dosage. Keep out of reach of children and do not transfer the medication to other containers.

Serious side effects

Hives, angioedema (including swelling of the lips, tongue, throat, and face)

Mild side effects

• Decreased libido
• erectile dysfunction
• ejaculation disorder
• decreased semen volume
• breast tenderness
• breast enlargement
• testicular pain
• blood in semen
• orgasm disorder
• male infertility

This medication is sensitive to air and moisture; it should be stored in a tightly closed container. The storage temperature should be maintained between 15 to 30 degrees Celsius.

Appearance

Brownish-yellow, biconvex, octagonal film-coated tablet

Package unit

30 tablets (10 tablets/PTP*3)